Literature DB >> 9299564

Helicobacter pylori vacuolating cytotoxin binds to the 140-kDa protein in human gastric cancer cell lines, AZ-521 and AGS.

K Yahiro1, T Niidome, T Hatakeyama, H Aoyagi, H Kurazono, P I Padilla, A Wada, T Hirayama.   

Abstract

To investigatie a potential mechanism of how Helicobacter pylori establishes infection, we purified a lot of vacuolating toxin (VacA) from supernatant of H. pylori ATCC49503 (tox+ strain 60190). We used an antibody which was prepared by immunizing rabbits with a synthetic peptide consisting of 16 amino acids reflecting a portion (Glu69-Arg83) of amino acid sequence of Vac A. VacA caused vacuoles in human gastric cancer cell lines AZ-521 AGS, and monkey kidney cell line COS-7, but not human promyeloblastic cell line HL-60. By immunoprecipitation analysis using anti VacA antibody, a biotinylated cell surface protein of 140kDa (p140) was precipitated only when the lysates of VacA-susceptible cells were incubated with VacA but not with inactivated VacA, indicating the association of p140 with VacA. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299564     DOI: 10.1006/bbrc.1997.7345

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Analysis of Helicobacter pylori vacA gene and serum antibodies to VacA in Japan.

Authors:  D Shirasaka; N Aoyama; K Satonaka; K Shirakawa; H Yoshida; T Sakai; T Ikemura; Y Shinoda; M Sakashita; M Miyamoto; K Yahiro; A Wada; H Kurazono; T Hirayama; M Kasuga
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

2.  How the loop and middle regions influence the properties of Helicobacter pylori VacA channels.

Authors:  F Tombola; C Pagliaccia; S Campello; J L Telford; C Montecucco; E Papini; M Zoratti
Journal:  Biophys J       Date:  2001-12       Impact factor: 4.033

3.  Dynamin is involved in human epithelial cell vacuolation caused by the Helicobacter pylori-produced cytotoxin VacA.

Authors:  J Suzuki; H Ohnsihi; H Shibata; A Wada; T Hirayama; T Iiri; N Ueda; C Kanamaru; T Tsuchida; H Mashima; H Yasuda; T Fujita
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

4.  Plasma membrane cholesterol modulates cellular vacuolation induced by the Helicobacter pylori vacuolating cytotoxin.

Authors:  Hetal K Patel; David C Willhite; Rakhi M Patel; Dan Ye; Christopher L Williams; Eric M Torres; Kent B Marty; Robert A MacDonald; Steven R Blanke
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

5.  The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH.

Authors:  D M Czajkowsky; H Iwamoto; T L Cover; Z Shao
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 6.  Helicobacter pylori VacA and gastric ulcer.

Authors:  Daisuke Shirasaka
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

7.  Serum-free culture of H pylori intensifies cytotoxicity.

Authors:  Hiroyuki Ohno; Akiyuki Murano
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

8.  Binding of the Helicobacter pylori vacuolating cytotoxin to target cells.

Authors:  P Massari; R Manetti; D Burroni; S Nuti; N Norais; R Rappuoli; J L Telford
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

9.  The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity.

Authors:  C Pagliaccia; M de Bernard; P Lupetti; X Ji; D Burroni; T L Cover; E Papini; R Rappuoli; J L Telford; J M Reyrat
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

10.  Identification of Helicobacter pylori VacA in human lung and its effects on lung cells.

Authors:  Shota Nakashima; Tomoyuki Kakugawa; Hirokazu Yura; Masaomi Tomonaga; Tatsuhiko Harada; Atsuko Hara; Shintaro Hara; Masayuki Nakano; Eiki Yamasaki; Noriho Sakamoto; Yuji Ishimatsu; Hajime Isomoto; Bernadette R Gochuico; Anthony F Suffredini; Hiroshi Mukae; Hisao Kurazono; Toshiya Hirayama; Joel Moss; Shigeru Kohno
Journal:  Biochem Biophys Res Commun       Date:  2015-03-25       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.